For the quarter ending 2026-03-31, HRGN made $226K in revenue. -$1,597K in net income. Net profit margin of -706.64%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Product revenue | 226 | 219 | 123 | 317 |
| Cost of sales | 206 | 25* | 112 | 302 |
| Research and development | 563 | 700 | 655 | 697 |
| Sales and marketing | 18 | 206* | 25 | 0 |
| General and administrative | 1,045 | 986 | 1,045 | 1,151 |
| Total operating expenses | 1,832 | 1,917 | 1,837 | 2,150 |
| Operating loss | -1,606 | -1,698 | -1,714 | -1,833 |
| Interest income | 2 | 6 | 11 | 7 |
| Interest expense | 2 | 1 | 2 | 3 |
| Other income | 5 | 6 | 5 | 6 |
| Other income (expense), net | 5 | 11 | 14 | 10 |
| Net loss | -1,601 | -1,687 | -1,700 | -1,823 |
| Foreign currency translation adjustments | 4 | -3 | -2 | -1 |
| Comprehensive loss | -1,597 | -1,690 | -1,702 | -1,824 |
| Basic EPS | -0.09 | -0.098 | -0.1 | -0.11 |
| Basic Average Shares | 17,580,744 | 17,197,437 | 17,033,109 | 15,918,979 |
Harvard Apparatus Regenerative Technology, Inc. (HRGN)
Harvard Apparatus Regenerative Technology, Inc. (HRGN)